Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(20%)

Results Posted

150%(3 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_4

20%

Ph not_applicable

20%

Ph early_phase_1

20%

Ph phase_3

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

1(25.0%)

Phase 3Large-scale testing

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Active, not recruiting1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (25.0%)

Phase 31 (25.0%)

Phase 41 (25.0%)

N/A1 (25.0%)

Trials by Status

terminated120%

active_not_recruiting120%

not_yet_recruiting120%

completed240%

Recent Activity

1 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

NCT07548346

active_not_recruiting

Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

NCT04001205

completedphase_4

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

NCT02701062

terminatedearly_phase_1

Statin Use in Patients With Acute VTE

NCT02331095

completedphase_3

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

NCT00896337

Clinical Trials (5)

Showing 5 of 5 trials

NCT07548346Not Applicable

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Not Yet Recruiting

NCT04001205

Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

Active Not Recruiting

NCT02701062Phase 4

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

Completed

NCT02331095Early Phase 1

Statin Use in Patients With Acute VTE

Terminated

NCT00896337Phase 3

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5